FDA classifies laser-powered IVC filter retrieval catheters as Class II devices
AI-generated summary for informational purposes only. Not legal advice. See the original source for the authoritative text.
This rule puts laser-powered inferior vena cava filter retrieval catheters into FDA Class II, which means companies can market them with special controls instead of facing automatic Class III treatment and premarket approval. The device makers must now meet specific testing, labeling, biocompatibility, sterility, shelf-life, and training requirements before sale. For manufacturers and compliance teams, the main impact is that these devices still need a 510(k) submission unless FDA exempts them, but the pathway is lighter than Class III. Hospitals and clinicians using the devices should expect clearer performance and training standards aimed at reducing risks like tissue damage, filter fracture, infection, and device failure.
AI-generated summary. May contain errors. Refer to official sources for legal decisions.
Key Changes
- FDA created a new Class II classification for laser-powered inferior vena cava filter retrieval catheters.
- Manufacturers must meet special controls, including clinical and non-clinical testing, laser compatibility testing, biocompatibility, sterility, shelf-life, labeling, and training requirements.
- The device remains subject to 510(k) premarket notification unless FDA later exempts it.
Obligations
What this law requires
Manufacturers of laser-powered inferior vena cava filter retrieval catheters must comply with FDA Class II special controls to lawfully market the device and avoid automatic Class III treatment.
Manufacturers must submit a premarket notification (510(k)) for the device unless FDA later exempts the device type from premarket notification requirements.
Clinical performance testing must demonstrate that the device performs as intended under anticipated conditions of use, including evaluation of major and minor complications from IVC filter removal and success rates of filter removal.
Non-clinical performance testing must evaluate dimensional compatibility, joint strength under tensile and torsional forces, simulated use performance, fluoroscopic visibility, and resistance to kinking under clinically relevant tortuosity.
Manufacturers must conduct compatibility testing with laser generators, including electrical safety, electromagnetic compatibility/interference testing, software verification and validation with hazard analysis where software is present, and laser output characterization/performance testing including calibration reliability, energy output, repetition rate, and laser lifetime.